Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 9Lung Neoplasms 9Breast Neoplasms 8Colorectal Neoplasms 6Hematopoietic and Lymphatic System Neoplasm 4Hematologic Neoplasms 2Fatigue 2Chronic Pain 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Neoplasm 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Syndrome 1Sunburn 1Spondylitis, Ankylosing 1Skin Neoplasms 1Sarcoma 1Pulmonary Embolism 1Psoriasis 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplastic Syndromes, Hereditary 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Malignant Solid Neoplasm 1

Interventions

deucravacitinib 1cabozantinib 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Methods 1Ipilimumab 1Interviews as Topic 1Exercise 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Psoriasis × Educational Status × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡